Covid-19: FDC launches two variants of the drug in India, price only Rs 55
1 min read
Covid-19: Researchers from all over the world are involved in making the corona virus vaccine. Different stages of vaccine trials are underway in many countries. Meanwhile, drug company FDC has launched PiFLU and Favenza, two variants of Favipiravir effective in treating Covid-19 in India. Its use has been approved for the treatment of patients with mild and moderate symptoms of corona.
